Furthermore, the notable associations observed between ITGAV and immune checkpoints, homologous recombination defects (HRD), microsatellite instability (MSI), and tumor mutation burden (TMB) indicate the involvement of ITGAV in tumor immunity, as depicted in Supplementary Figures S3A–D. Here, ITGAV is linked to neoplasm.